Literature DB >> 21108394

High carriers frequency of an apparently ancient founder mutation p.Tyr322X in the ERCC8 gene responsible for Cockayne syndrome among Christian Arabs in Northern Israel.

Morad Khayat1, Hagar Hardouf, Joel Zlotogora, Stavit Allon Shalev.   

Abstract

Most autosomal recessive diseases are rare in the general population, but in genetically isolated communities specific condition might be frequent, mainly due to founder effect. Recognition of common inherited disorders in defined populations may be effective in improving public health care. Cockayne syndrome (CS) is a rare autosomal recessive disorder common in Christian Arabs due to a p.Tyr322X mutation. Genetic screening of the p.Tyr322X mutation of the ERCC8 gene in this population documented a carrier frequency of 6.79% (95% confidence interval: 3.84-9.74%). The haplotype analysis data, as well as the high carriers frequency of CS, suggested that the Israeli Arab Christian CS mutation (p.Tyr322X) is an ancient founder mutation that may have originated in the Christian Lebanese community. As a result of this pilot study the Christian CS mutation was included in the genetic screening program offered to the Israeli Arab Christian community.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21108394     DOI: 10.1002/ajmg.a.33746

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

1.  A review of the diverse genetic disorders in the Lebanese population: highlighting the urgency for community genetic services.

Authors:  Ghunwa Nakouzi; Khalil Kreidieh; Soha Yazbek
Journal:  J Community Genet       Date:  2014-09-27

Review 2.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

3.  A recurrent pathogenic BRCA2 exon 5-11 duplication in the Christian Arab population in Israel.

Authors:  Hagit Baris-Feldman; Karin Weiss; Gili Reznick Levi; Gal Larom; Vered Ofen Glassner; Nina Ekhilevitch; Nitzan Sharon Swartzman; Tamar Paperna
Journal:  Fam Cancer       Date:  2021-05-17       Impact factor: 2.446

4.  The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for care.

Authors:  Brian T Wilson; Zornitza Stark; Ruth E Sutton; Sumita Danda; Alka V Ekbote; Solaf M Elsayed; Louise Gibson; Judith A Goodship; Andrew P Jackson; Wee Teik Keng; Mary D King; Emma McCann; Toshino Motojima; Jennifer E Murray; Taku Omata; Daniela Pilz; Kate Pope; Katsuo Sugita; Susan M White; Ian J Wilson
Journal:  Genet Med       Date:  2015-07-23       Impact factor: 8.822

5.  The Israeli National Genetic database: a 10-year experience.

Authors:  Joël Zlotogora; George P Patrinos
Journal:  Hum Genomics       Date:  2017-03-16       Impact factor: 4.639

6.  Heterogeneous clinical features in Cockayne syndrome patients and siblings carrying the same CSA mutations.

Authors:  Asma Chikhaoui; Ichraf Kraoua; Nadège Calmels; Sami Bouchoucha; Cathy Obringer; Khouloud Zayoud; Benjamin Montagne; Ridha M'rad; Sonia Abdelhak; Vincent Laugel; Miria Ricchetti; Ilhem Turki; Houda Yacoub-Youssef
Journal:  Orphanet J Rare Dis       Date:  2022-03-05       Impact factor: 4.123

7.  Molecular spectrum of excision repair cross-complementation group 8 gene defects in Chinese patients with Cockayne syndrome type A.

Authors:  Xiaozhu Wang; Yu Huang; Ming Yan; Jiuwei Li; Changhong Ding; Hong Jin; Fang Fang; Yanling Yang; Baiyan Wu; Dafang Chen
Journal:  Sci Rep       Date:  2017-10-20       Impact factor: 4.379

8.  Identification and Characterization of a Novel Recurrent ERCC6 Variant in Patients with a Severe Form of Cockayne Syndrome B.

Authors:  Khouloud Zayoud; Ichraf Kraoua; Asma Chikhaoui; Nadège Calmels; Sami Bouchoucha; Cathy Obringer; Clément Crochemore; Dorra Najjar; Sinda Zarrouk; Najoua Miladi; Vincent Laugel; Miria Ricchetti; Ilhem Turki; Houda Yacoub-Youssef
Journal:  Genes (Basel)       Date:  2021-11-29       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.